Increased EE apoptosis (caspase-3 activation and TUNEL/CD-31 co-labeling) in AVF mice was prevented in the MMP-9KO+AVF group. PAR-1, connexin-43 and ADAM-12 were induced in AVF. MMP-9 gene ablation ameliorated the induction.
ABSTRACT: Accumulation of oxidized extracellular matrix (ECM) between endothelium and muscle is an important risk factor in the endothelium-myocytes (E-M) uncoupling in congestive heart failure (CHF). Although ventricular remodeling is accompanied by increased matrix metalloproteinase-9 (MMP-9) activity, it is unclear whether MMP-9 plays a role in endothelial apoptosis in chronic volume overload CHF. We tested the hypothesis that in chronic volume overload, myocardial dysfunction involves endocardial endothelial (EE) apoptosis in response to MMP-9 activation, ECM accumulation and E-M uncoupling. (ADAM-12) expression were measured by Western blot analyses. MMP-2 and MMP-9 expression were measured by Q-RT-PCR. Results: Compared to control, AVF caused an increase in LVEDP and decrease in -dP/dt. In contrast, in MMP-9KO+AVF group, these variables were changed toward control levels.
INTRODUCTION:
Myocardial remodeling in congestive heart failure (CHF) is associated with accumulation of extracellular matrix (ECM) between endothelial and muscle cells (21) and is one of the most important factors of endocardial endothelial (EE) dysfunction (8, 14) . Previous studies showed that morphological changes in myocardium are associated with increased expression and activity of matrix metalloproteinases (MMPs) (6, 18) . MMPs degrade interstitial collagen and elastin, but the more collagen is degraded, the more that is synthesized.
Consequently, synthesis exceeds degradation and leads to accumulation of oxidized ECM (19, 29) . ECM accumulation leads to increased endothelial to myocyte distance (20) and, recently, we showed that activation of MMPs leads to endothelial-myocyte uncoupling (21). There are more than 20 MMPs in the family, but MMP-2 and MMP-9 are the most robustly increased during early and late phase of CHF, respectively (28). Different stimuli, including cardiac mechanical stress and overload have been found to increase the rate of myocardial apoptosis, a process of programmed cell death (10) . It has been found that myocyte apoptosis is one of the factors in developing of CHF, but the role of endocardial apoptosis in progression of cardiac dysfunction remains controversial (17) . The capillary endothelium, strategically located between flowing blood and underlying cardiac muscle, plays an important role in controlling myocardial performance (19) . In fact, sixteen percent of the myocardium consists of capillaries, including lumen and endothelium (11) . We hypothesized that in a chronic heart volume overload model and the late phase of CHF, myocardial dysfunction involves endothelial apoptosis in response to MMP-9 activation, ECM accumulation and endothelial-myocyte (E-M) uncoupling.
Previously, we demonstrated that tissue inhibitor of metalloproteinase-4 (TIMP-4) ameliorated the endothelial cell apoptosis, in part by inhibiting MMPs (22). To demonstrate a direct role of MMP in apoptosis, we tested the hypothesis that ablation of MMP-9 gene can also alleviate the endothelial cell apoptosis in heart failure.
MATERIALS AND METHODS
All mice were exposed to a similar environment and all animal procedures were approved by the Institutional Animal Care and Use Committee of the University of Louisville Medical Center. Male mice aged 8 to 12 weeks, MMP-9 knockout (MMP-9KO, FVB.Cg-Mmp9 tm1Tvu ) and FVB/NJ controls (2), were obtained from Jackson Laboratories (Bar Harbor, Maine). An arteriovenous fistula (AVF) was created between the aorta and the caudal vena cava approximately 0.5 cm below the left kidney with the use of a 30-gauge needle as described (7) in tribromoethanolanesthetized mice (100 mg/kg IP; n=12) (16) . Mice were divided into 4 groups: 1). WT (FVB/NJ control); 2). WT plus AVF; 3). MMP9KO; and 4). 
Measurements of aortic and LV blood pressure: The Millar transducer
was calibrated manually using a mercury manometer. The arterial blood pressure, heart rate (HR), systolic and diastolic blood pressure were measured by a pressure tipped Millar transducer (SPR-249A) inserted into the right common carotid artery.
Ten minutes after stabilization, the aortic pressure was measured by advancing the catheter into the LV. The catheter was connected to a pressure transducer (Micro-Med Corp.) positioned at the level of the heart. Ten minutes after the insertion of the catheter, LV variables were measured (4) . LVESP, LVEDP, and -dP/dt, were measured. At the end of experiment, the anesthetized mice were prepared for the excision of the lungs and arrested heart.
MMPs activity: Zymography using 1% gelatin gels were performed on LV tissue homogenates as described (29). 
MMP-2 and MMP-9 expression by Q-RT-PCR

Western blot analysis of PAR-1, ADAM-12, connexin-43, and caspase-3:
LV tissue homogenates were prepared, analyzed on 10% SDS-PAGE, and transferred to PVDF membranes. Twenty five micrograms of total protein were loaded on to each lane. The membranes were blotted with anti-caspase-3, PAR-1, ADAM-12, or connexin-43 monoclonal antibodies (Cell signaling and Chemicon) as previously described (4) . The secondary IgG-alkaline phosphatase was used for detection. Actin blots were used as a loading control. The bands were scanned and normalized with actin intensity. The gels were stained with Commassie blue for protein. 
TUNEL and CD-31 immunohistochemical labeling:
RESULTS:
Hemodynamic variables: Mean arterial blood pressure (MAP) and heart rate (HR) (67.9±0.8 mmHg, n=3 and 408.8±9 beats/min, n=3, respectively) were not significantly different between all groups (12 animals). Although the body weight (26.7±0.5 g) was not significantly different between all groups, the heart weight was significantly increased in AVF mice compared to controls (WT and MMP9KO groups) ( Table 1) suggesting cardiac hypertrophy in mice with chronic volume overload. The histological data revealed biventricular hypertrophy in AVF mice. In addition, compared to WT, the focal fibrosis was also increased in left and right ventricles in the animals from the AVF group (Figure 1 ). In contrast, there was no hypertrophy or focal fibrosis in WT, MMP-9KO and MMP-9KO+AVF mice.
In AVF animals, compared to controls, LVESP was decreased and LVEDP was increased. In those animals, the -dP/dt normalized by MAP, was significantly decreased, suggesting that LV diastolic relaxation is decreased in AVF animals compared to controls (Table1). LV systolic dysfunction in AVF animals was shown by LVESP/HW ratio (Table1). In contrast, both diastolic and systolic dysfunctions were prevented in MMP9KO+AVF mice (Table1).
Role of MMP-9 in cardiac remodeling: Total MMP activity in heart tissue was significantly increased in the AVF group compared to WT. The Q-RT-PCR data also showed increased MMP-9 mRNA expression in heart tissue from AVF animals ( Figure 2 ). Although the basal levels of MMP-2 were higher in MMP-9 -/mice then in WT, there was a significant increase in MMP-2 expression in AVF compared to both WT and MMP-9KO groups (Figure 2 ). Compared to WT, the level of PAR-1 expression was significantly increased in AVF animals, but ablation of MMP-9, in animals that underwent AVF, ameliorated the increase (Figure 3) . Similarly, the heart tissue expressions of ADAM-12 and connexin-43, which significantly increased in the AVF group, were attenuated in MMP9KO+AVF animals (Figures 4 and 5) . These data suggest that AVF-induced MMP-9 is involved in PAR-1, ADAM-12, and connexin-43 over expression.
Cardiac function:
The LV dilatation and LV wall thickness measured by echocardiography revealed that the LV wall /LV EDD ratio was significantly decreased in AVF group compared to controls, and ablation of MMP-9 in MMP9KO+AVF animals prevented this decrease ( Figure 6) . These data suggest a role of MMP-9 in cardiac dilatation in congestive heart failure.
Endothelial and myocyte apoptosis:
There was significant induction of caspase-3 in AVF hearts as compared to WT or MMP-9KO, with or without AVF ( Figure 7 ). There were higher numbers of TUNEL positive cells (Figure 8 The increase in caspase-3 activation and TUNEL was prevented in MMP9KO+AVF animals. The co-labeling of TUNEL and CD-31, as a marker for endothelial cells in serial heart tissue sections, demonstrated that endothelial cells underwent apoptosis (Figure 9 ). Based on TUNEL positive and CD-31 positive versus CD-31 negative cells, we estimated that 75% TUNEL positive cells were endothelial origin (Table II) . Besides those cells, there were other TUNEL positive cells, suggesting that endothelial, as well as myocyte apoptosis, is involved in this chronic heart failure model (Table II) . The induction of caspase-3 and in situ TUNEL in the LV of AVF suggest involvement of MMP-9 in transduction of apoptosis.
DISCUSSION
We and others suggested the role of endocardial apoptosis in the cardiac dysfunction in congestive heart failure (27, 31). However, the mechanism of this phenomenon is still unknown (1, 18) . The results of the present study show that impaired cardiac function in chronic volume overload CHF is associated with endothelial and myocyte apoptosis and is accompanied by endothelial-myocyte uncoupling in response to MMP-9 activation. MMPs are potential mediators of cardiac remodeling and progression to heart failure. Previously, we showed that during the compensatory phase of CHF, MMP-2 is increased and MMP-9 is over expressed (23). Others have suggested that targeted deletion of MMP genes in mice attenuates cardiac remodeling in acute (6, 9, 26) and in LV pressure overload heart failure models (10) . In the present study we demonstrated molecular and cellular mechanisms that mediate the pathogenesis of chronic heart failure, and the involvement of MMPs in cardiac remodeling and dysfunction.
The histological and gravimetrical data suggested that cardiac hypertrophy in mice with chronic volume overload heart failure were associated with ECM accumulation (Figure 1 ). We obtained histological data on MMP-9KO similar to the data obtained by others (6) and found that there was no significant difference in MMP-9KO (control and AVF). The total MMP-2 and MMP-9 expressions were significantly increased in animals from the AVF group ( Figure 2 ). We measured total MMP and MMP-9 expression in MMP-9KO animals (control and AVF), and found that there was no expression of MMP-9 in control and AVF. However, there was increased MMP-2 expression ( Figure 2 ). This finding is in part due to a compensatory response to MMP-9 ablation (6). In addition, the lung weight from the AVF animals was significantly higher then controls, suggesting pulmonary edema ( Table 1) . A significant decrease in the LV wall /LV EDD ratio, changes in LV ESP and LV EDP , decrease in LV contraction and relaxation suggested that cardiac function in those animals was also impaired (Table 1 and Figure 6 ). The ablation of MMP-9 in animals with AVF significantly normalized LV parameters, and clearly indicates that MMP-9 plays a crucial role in pathogenesis of chronic heart failure. These results are consistent with previous reports that MMP-9 inhibition, or targeted deletion of the MMP-9 gene in mice, attenuates LV dilation and decreases collagen accumulation in the infarcted area after experimental MI (6) or after AVF (3) or after pressure overload (10) .
Our hypothesis was that impaired cardiac function in CHF could be the consequence of endothelial apoptosis in response to E-M uncoupling due to ECM accumulation in the myocardium (Figure 10 ). We found that the levels of caspase-3 activation and numbers of TUNEL positive cells in heart tissue of AVF animals were significantly higher than in controls (Figures 7 and 8) . Serial heart tissue sections were immunochemically developed with CD-31 antibody as a label for endothelial cells and TUNEL for apoptosis. This TUNEL/CD-31 colabeling showed that endothelial, as well as myocyte apoptosis, is involved in pathogenesis of CHF ( Figure 9 ). Previously, we reported that activated PAR-1 lead to the cardiac remodeling (21) and inhibition of MMPs prevented connexin-43 degradation and ameliorated heart failure (13) . In the present study, we found that besides increased expression of PAR-1, ADAM-12 (a disintegrin and metalloprotease), enzyme involved in cell adhesion and myoblast differentiation and fusion (15) , was also over expressed in AVF animals. This finding suggests that increased activity of PAR-1 could lead activation of several proteolytic events. It was shown previously that reduced Connexin-43 expression produces uncoupling between myocytes (24). In our model, increased expression of connexin-43 might be associated with E-M uncoupling due to a compensatory response to cell disintegration by ADAM-12. However, further studies are needed to confirm the relationship between PAR-1 and connexin-43 remodeling by ADAM-12. The results of our experiments show that in animals from MMP9KO+AVF, the increase in the levels of apoptosis was prevented (Figures 8   and 9 ). In addition, PAR-1, ADAM-12 and connexin-43 expressions were also normalized (Figures 3-5 ).
Limitations: TUNEL detection alone is not enough to confirm apoptotic death (12, 25, and 30) . Therefore, we measured the levels of caspase-3, and showed that a caspase-3 inhibitor ameliorated the endothelial cell apoptosis (22).
Here, we suggested that caspase-3 was significantly induced in AVF hearts as compared with the sham or the MMP-9-/-mouse hearts with and without AVF ( Figure 7) . These results suggested apoptosis in the AVF hearts, in part, due to activation of caspase-3.
The connection between PAR-1 and connexin-43 may not be strong.
However, in light of our human heart end-stage failure data, in which we showed that connexin-43 synthesis and degradation both were increased, and MMPs were activated in CHF (22). It is a logical extension of the idea that volume overload stress activated the MMP that in turn activated PAR-1, leading to induction of connexin-43 in AVF.
In summary, the results of the present study demonstrate that in chronic volume overload model of CHF in mice, impaired cardiac function is associated with endothelial and myocyte apoptosis. The mechanism of these phenomena involves activation of MMP-9, leading to cardiac remodeling and E-M uncoupling.
Our study also shows that MMP-9 has a major role in ventricular remodeling associated with endothelial and myocyte apoptosis (Figure 10 ). 
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